hhvb glp-1 fda approved Compounding Crackdown New GLP-1 Pill Foundayo (Orforglipron)

Competing Interests Blair Suter, Allison Bigeh, Timothy Frommeyer, and Laxmi Mehta declare that they have no conflicts of interest

These drugs have shown to be very effective in producing weight loss in patients

Agents that have been shown to be remarkably effective in promoting weight loss and improving metabolic outcomes include liraglutide, semaglutide, and tirzepatide

Side effects are a common reason for quitting a GLP-1 early, research suggests

Like its peers, it pairs compounded semaglutide and tirzepatide with licensed clinical oversight and home delivery and adds a microdosing option for a gentler start

Drugs (2015) 75(10):11614